The company is set to draft in a PR agency within three weeks to promote its range of contraceptives, which are facing competition from rivals such as Janssen-Cilag’s Evra patch.
Comms manager Andrew Greaves said three undisclosed agencies had pitched for the account last week and that the PR agency hire would be Organon’s first for its contraceptive brands for ‘at least two years’.
Organon hit the headlines last September when it withdrew an ad for its progestogen-only pill Cerazette that claimed the mini-pill was as effective as combined pills in preventing unwanted pregnancy.
The ad, published in medical journals, was withdrawn following criticism in the Consumers’ Association’s journal Drug and Therapeutics Bulletin.
The PR agency will promote Cerazette, plus the Mercilon, Implanon, Marvelon and Multiload brands, via PR such as ‘consumer education’ and PR work targeting clinicians.
Organon has its global headquarters in Amsterdam and its UK headquarters in Cambridge. It continues to retain Portcullis Public Affairs and other freelance PROs.
Organon, which wants to launch its NuvaRing brand in the UK before the end of 2005, is also working alongside Schering to develop a male pill.